Intellia Therapeutics Inc... (NTLA)
NASDAQ: NTLA
· Real-Time Price · USD
10.99
0.09 (0.83%)
At close: Aug 15, 2025, 3:59 PM
11.01
0.18%
After-hours: Aug 15, 2025, 07:57 PM EDT
Intellia Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 14.24M | 16.63M | 12.87M | 9.11M | 6.96M | 28.93M | -1.92M | 11.99M | 13.59M | 12.61M | 13.57M | 13.27M | 14.03M | 11.25M | 12.85M | 7.2M | 6.55M | 6.45M |
Cost of Revenue | n/a | n/a | 2.57M | 2.61M | 2.6M | 2.51M | 2.47M | 2.29M | 2.17M | 2.05M | 2.03M | 96.65M | 1.84M | 1.75M | 1.88M | 60.49M | 58.88M | 39.28M |
Gross Profit | 14.24M | 16.63M | 7.7M | 9.11M | 4.36M | 26.42M | -4.38M | 9.7M | 11.42M | 10.56M | 11.54M | -83.39M | 12.19M | 9.5M | 10.97M | -53.28M | -52.33M | -32.83M |
Operating Income | -110M | -120.81M | -136.45M | -144.77M | -139.04M | -114M | -139.89M | -131.11M | -132.33M | -111.96M | -110.09M | -105.53M | -98.3M | -144.25M | -80.42M | -71.99M | -69.02M | -46.42M |
Interest Income | 7.4M | 8.6M | 10.63M | 12.12M | 12.42M | 12.63M | 12.46M | 12.74M | 12.65M | 11.98M | 5.35M | 1.95M | 703K | 540K | 503K | 349K | 211K | 220K |
Pretax Income | -101.25M | -114.33M | -128.9M | -135.71M | -146.97M | -107.44M | -132.16M | -122.22M | -123.68M | -103.13M | -113.41M | -113.23M | -100.68M | -146.87M | -81.24M | -71.64M | -68.81M | -46.2M |
Net Income | -101.25M | -114.33M | -128.9M | -135.71M | -146.97M | -107.44M | -132.16M | -122.22M | -123.68M | -92.34M | -116.73M | -113.23M | -99.97M | -146.87M | -81.24M | -71.64M | -68.81M | -46.2M |
Selling & General & Admin | 27.21M | 29.01M | 32.44M | 30.5M | 31.79M | 31.09M | 28.99M | 29.4M | 30.65M | 27.45M | 23.63M | 22.14M | 22.13M | 22.4M | 22.11M | 18.71M | 16.68M | 13.59M |
Research & Development | 97.03M | 108.43M | 114.31M | 123.38M | 111.61M | 109.33M | 108.98M | 113.7M | 115.28M | 97.12M | 100.03M | 96.65M | 90.2M | 133.09M | 71.16M | 60.49M | 58.88M | 39.28M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | -2.47M | -2.29M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 124.24M | 137.43M | 146.75M | 153.88M | 143.4M | 140.43M | 135.51M | 140.81M | 145.93M | 124.56M | 123.66M | 118.8M | 112.33M | 155.5M | 93.27M | 79.2M | 75.57M | 52.87M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 124.24M | 137.43M | 149.32M | 153.88M | 146M | 142.94M | 137.97M | 143.1M | 145.93M | 124.56M | 123.66M | 118.8M | 112.33M | 155.5M | 93.27M | 79.2M | 75.57M | 52.87M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -10.78M | 3.32M | n/a | -703K | -119K | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 103.73M | 103.5M | 101.86M | 101M | 96.97M | 95.5M | 90.46M | 88.64M | 88.19M | 87.77M | 81.22M | 76.05M | 75.7M | 74.75M | 74.43M | 73.71M | 68.16M | 67.18M |
Shares Outstanding (Diluted) | 103.73M | 103.5M | 101.86M | 101M | 96.97M | 95.5M | 90.46M | 88.64M | 88.19M | 87.77M | 81.22M | 76.05M | 75.82M | 74.75M | 74.43M | 73.71M | 68.16M | 67.18M |
EPS (Basic) | -0.98 | -1.1 | -1.27 | -1.34 | -1.52 | -1.12 | -1.46 | -1.38 | -1.4 | -1.05 | -1.44 | -1.49 | -1.32 | -1.96 | -1.09 | -0.97 | -1.01 | -0.69 |
EPS (Diluted) | -0.98 | -1.1 | -1.27 | -1.34 | -1.52 | -1.12 | -1.46 | -1.38 | -1.4 | -1.05 | -1.44 | -1.49 | -1.32 | -1.96 | -1.09 | -0.97 | -1.01 | -0.69 |
EBITDA | -107.52M | -118.31M | -133.88M | -142.16M | -136.44M | -111.49M | -137.43M | -128.82M | -130.16M | -109.91M | -108.06M | -103.58M | -96.46M | -142.49M | -78.53M | -70.21M | -67.38M | -44.83M |
EBIT | -110M | -120.81M | -136.45M | -144.77M | -139.04M | -114M | -139.89M | -131.11M | -132.33M | -111.96M | -110.09M | -105.53M | -98.3M | -144.25M | -80.42M | -71.99M | -69.02M | -46.42M |
Depreciation & Amortization | 2.47M | 2.5M | 2.57M | 2.61M | 2.6M | 2.51M | 2.47M | 2.29M | 2.17M | 2.05M | 2.03M | 1.95M | 1.84M | 1.75M | 1.88M | 1.79M | 1.63M | 1.59M |